| Literature DB >> 15705861 |
Elise Bales1, Lisa Mills, Nancy Milam, Mollianne McGahren-Murray, Debdutta Bandyopadhyay, Dahu Chen, Jon A Reed, Nikolai Timchenko, Joost J van den Oord, Menashe Bar-Eli, Khandan Keyomarsi, Estela E Medrano.
Abstract
Immunohistochemical analysis has consistently shown that cyclin E is up-regulated in human malignant melanomas in vivo. Here we analyzed such expression in more detail and show that cyclin E is overexpressed and present in low molecular weight (LMW) isoforms in metastatic melanoma and in a subset of primary invasive melanoma tumor tissues, but not in benign nevi. Human metastatic melanoma cell lines, but not normal melanocytes, also expressed the LMW cyclin E forms. The biological significance of these findings was established by showing that overexpression of two LMW cyclin E forms named cyclin E truncated 1 [cyclinE(T1)] and cyclin E truncated 2 [cyclinE(T2)] in a low tumorigenic and non-metastatic primary cutaneous melanoma cell line generated angiogenic tumors with prominent perineural invasion compared with full-length cyclin E. In addition, cyclin E(T1)- and cyclin E(T2)-expressing melanoma cells displayed a dramatic increase in the incidence and number of metastases in an experimental lung metastasis assay. Together, these results indicate that the LMW cyclin E forms are functional and likely act as regulators of human melanoma tumor progression and invasion.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15705861
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701